Compare The Vita Coco Company Inc (COCO) vs Xpeng Inc - ADR (XPEV) Price & Performance

The Vita Coco Company (COCO) trades at $62.25, down 2.92% over 24 hours, with a bullish technical signal driven by oversold RSI readings and support near $62. Fundamentally, Q2 2026 earnings beat expectations with EPS of $0.82 versus $0.56 estimated, while revenue grew 28% year-over-year to $216 million. The company raised full-year 2026 guidance, reflecting strong demand and the Copra acquisition.

Outlook remains positive with 60% analyst buy ratings and an $80.67 consensus price target, implying ~30% upside. Key risks include margin pressure from rising costs and capacity constraints. Growth catalysts include international expansion and health-focused innovation in the beverage sector.

XPeng (XPEV) trades at $12.13, up 3.85% in the last session, with a bearish technical signal from moving averages but oversold RSI levels. The company reported revenue of $76.72 billion in 2025, with narrowing losses and a negative net income margin of -3.06%. Recent news highlights expansion into robotics and autonomous vehicles, with July 2026 deliveries up 4% year-over-year (PRNewsWire, August 1, 2026).

The outlook is mixed: analyst consensus is bullish with a $17.00 price target (64.7% buy ratings), but risks include persistent losses, high debt-to-asset ratio of 13.63 (2025), and intense EV competition. Upside potential hinges on new model launches and global growth, while cash flow volatility and macroeconomic pressures pose headwinds.